Atala Financial Inc Takes $1.69 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Atala Financial Inc bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 21,653 shares of the company’s stock, valued at approximately $1,693,000. GE HealthCare Technologies accounts for about 1.2% of Atala Financial Inc’s portfolio, making the stock its 26th largest position.

Other institutional investors have also recently modified their holdings of the company. Commonwealth Equity Services LLC boosted its holdings in GE HealthCare Technologies by 49.7% in the 4th quarter. Commonwealth Equity Services LLC now owns 245,476 shares of the company’s stock worth $19,191,000 after buying an additional 81,552 shares during the last quarter. PGGM Investments acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $579,000. Bowen Hanes & Co. Inc. boosted its holdings in GE HealthCare Technologies by 3.3% in the 4th quarter. Bowen Hanes & Co. Inc. now owns 18,845 shares of the company’s stock worth $1,473,000 after buying an additional 600 shares during the last quarter. Skandinaviska Enskilda Banken AB publ boosted its holdings in GE HealthCare Technologies by 6.1% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 94,713 shares of the company’s stock worth $7,445,000 after buying an additional 5,412 shares during the last quarter. Finally, Achmea Investment Management B.V. boosted its holdings in GE HealthCare Technologies by 39.6% in the 4th quarter. Achmea Investment Management B.V. now owns 26,796 shares of the company’s stock worth $2,095,000 after buying an additional 7,596 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently weighed in on GEHC shares. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $85.00 to $100.00 in a report on Tuesday. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Finally, Citigroup boosted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Stock Down 2.8 %

GEHC stock opened at $81.45 on Friday. The firm has a market cap of $37.25 billion, a PE ratio of 18.81, a PEG ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The firm’s 50 day moving average price is $87.17 and its 200-day moving average price is $86.16.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.